Curated News
By: NewsRamp Editorial Staff
October 30, 2026
SS Innovations Shows Remote Robotic Heart Surgery Across 7,500 Miles
TLDR
- SS Innovations' SSi Mantra enables remote cardiac telesurgery, positioning SSII ahead in robotic surgery as it targets FDA 510(k) clearance in Q1 2027.
- The SSi Mantra system with SSi MantrAsana console allows surgeons to perform robotic procedures remotely, as shown in a 7,500-mile cardiac telesurgery and four other broadcasts.
- Remote robotic surgery with SSi Mantra can extend specialist care to underserved areas, potentially improving access to complex procedures and making healthcare more equitable.
- SS Innovations has reported 205 telesurgeries with SSi Mantra as of October 2026, including a cardiac procedure performed from 7,500 miles away.
Impact - Why it Matters
This news matters because it demonstrates a significant leap in telemedicine and robotic surgery, potentially allowing patients in remote or underserved areas to receive expert surgical care without travel. The successful long-distance cardiac procedure and other telesurgeries highlight the viability of remote robotic operations, which could reduce healthcare disparities and improve access to specialized treatments. As SS Innovations pursues FDA clearance, the technology may soon become available in the U.S., offering new options for patients and expanding the reach of skilled surgeons. The progress also signals growing competition and innovation in the surgical robotics market, with implications for healthcare costs, outcomes, and delivery models.
Summary
SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console at two international medical conferences in October 2026, demonstrating the potential of remote robotic surgery. At the 40th European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted atrial septal defect procedure on a patient approximately 7,500 miles away in Bengaluru, India. This feat highlighted the ability to extend specialized surgical expertise across vast distances.
In addition, four other robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures. The company reported that as of October 23, 2026, 205 telesurgeries have been performed with the SSi Mantra system, including cardiac procedures. These demonstrations underscore the growing feasibility of remote robotic surgery, although widespread adoption will depend on clinical validation, connectivity, and regulatory approvals. SS Innovations is currently pursuing U.S. Food and Drug Administration clearance for the SSi Mantra, with completion of the 510(k) review targeted for the first quarter of 2027, subject to the FDA’s review timeline.
The events mark significant milestones for SS Innovations as it seeks to revolutionize surgical care through robotics and telemedicine. By enabling surgeons to operate on patients remotely, the technology could help address disparities in access to specialized care, particularly in underserved regions. The company’s progress with the FDA will be closely watched as it moves toward bringing its platform to the U.S. market. For more details, read the full announcement (Read More>>).
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Shows Remote Robotic Heart Surgery Across 7,500 Miles
